BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12893022)

  • 1. The 2756A>G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study.
    Klerk M; Lievers KJ; Kluijtmans LA; Blom HJ; den Heijer M; Schouten EG; Kok FJ; Verhoef P
    Thromb Res; 2003 May; 110(2-3):87-91. PubMed ID: 12893022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the 2756A> G variant in the gene encoding methionine synthase and myocardial infarction in Tunisian patients.
    Jemaa R; Achouri A; Kallel A; Ben Ali S; Mourali S; Feki M; Elasmi M; Taieb SH; Sanhaji H; Omar S; Mechmeche R; Kaabachi N
    Clin Chem Lab Med; 2008; 46(10):1364-8. PubMed ID: 18844488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between common folate polymorphisms and B-vitamin nutritional status modulates homocysteine and risk for a thrombotic event.
    Yates Z; Lucock M
    Mol Genet Metab; 2003 Jul; 79(3):201-13. PubMed ID: 12855226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma homocysteine concentrations and the single nucleotide polymorphisms in the methionine synthase gene (MTR 2756A>G): Associations with the polycystic ovary syndrome An observational study.
    Palep-Singh M; Picton HM; Yates ZR; Barth JH; Balen AH
    Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):180-6. PubMed ID: 18281142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction.
    Chen J; Stampfer MJ; Ma J; Selhub J; Malinow MR; Hennekens CH; Hunter DJ
    Atherosclerosis; 2001 Feb; 154(3):667-72. PubMed ID: 11257268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk.
    Ma J; Stampfer MJ; Christensen B; Giovannucci E; Hunter DJ; Chen J; Willett WC; Selhub J; Hennekens CH; Gravel R; Rozen R
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):825-9. PubMed ID: 10498402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of combined MTR and MTHFR genotypes among individuals with severely elevated total homocysteine plasma levels.
    Feix A; Fritsche-Polanz R; Kletzmayr J; Vychytil A; Hörl WH; Sunder-Plassmann G; Födinger M
    Am J Kidney Dis; 2001 Nov; 38(5):956-64. PubMed ID: 11684547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study.
    Jacques PF; Bostom AG; Selhub J; Rich S; Ellison RC; Eckfeldt JH; Gravel RA; Rozen R;
    Atherosclerosis; 2003 Jan; 166(1):49-55. PubMed ID: 12482550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolism.
    Semmler A; Moskau-Hartmann S; Stoffel-Wagner B; Elger C; Linnebank M
    Clin Chem Lab Med; 2013 Mar; 51(3):665-9. PubMed ID: 23382314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency of a common mutation of the methionine synthase gene in the Australian population and its relation to smoking and coronary artery disease.
    Wang XL; Cai H; Cranney G; Wilcken DE
    J Cardiovasc Risk; 1998; 5(5-6):289-95. PubMed ID: 9919998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relations of methionine synthase gene variation with congenital heart disease].
    Zhu W; Dao J; Cheng J; Zhao R
    Wei Sheng Yan Jiu; 2004 Jan; 33(1):66-9. PubMed ID: 15098482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men.
    Chambers JC; Obeid OA; Refsum H; Ueland P; Hackett D; Hooper J; Turner RM; Thompson SG; Kooner JS
    Lancet; 2000 Feb; 355(9203):523-7. PubMed ID: 10683001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations.
    Harmon DL; Shields DC; Woodside JV; McMaster D; Yarnell JW; Young IS; Peng K; Shane B; Evans AE; Whitehead AS
    Genet Epidemiol; 1999 Nov; 17(4):298-309. PubMed ID: 10520212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of combined methionine synthase (MTR 2756A > G) and methylenetetrahydrofolate reductase (MTHFR 677C > T) polymorphisms to plasma homocysteine levels in Korean patients with ischemic stroke.
    Kim OJ; Hong SP; Ahn JY; Hong SH; Hwang TS; Kim SO; Yoo W; Oh D; Kim NK
    Yonsei Med J; 2007 Apr; 48(2):201-9. PubMed ID: 17461517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between methionine synthase, methionine synthase reductase genetic polymorphisms and deep vein thrombosis among South Indians.
    Naushad SM; Jain Jamal MN; Prasad CK; Rama Devi AR
    Clin Chem Lab Med; 2008; 46(1):73-9. PubMed ID: 18034637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case-control analysis.
    Shi Q; Zhang Z; Li G; Pillow PC; Hernandez LM; Spitz MR; Wei Q
    Pharmacogenet Genomics; 2005 Aug; 15(8):547-55. PubMed ID: 16006998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The methionine synthase polymorphism c.2756A>G alters susceptibility to glioblastoma multiforme.
    Semmler A; Simon M; Moskau S; Linnebank M
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2314-6. PubMed ID: 17119065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease.
    Brown CA; McKinney KQ; Kaufman JS; Gravel RA; Rozen R
    J Cardiovasc Risk; 2000 Jun; 7(3):197-200. PubMed ID: 11006889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease.
    Laraqui A; Allami A; Carrié A; Coiffard AS; Benkouka F; Benjouad A; Bendriss A; Kadiri N; Bennouar N; Benomar A; Guedira A; Raisonnier A; Fellati S; Srairi JE; Benomar M
    Acta Cardiol; 2006 Feb; 61(1):51-61. PubMed ID: 16485733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.